These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms. Angelov SN; Hu JH; Wei H; Airhart N; Shi M; Dichek DA Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2102-2113. PubMed ID: 28729364 [TBL] [Abstract][Full Text] [Related]
12. Rapamycin Treatment Attenuates Angiotensin II -induced Abdominal Aortic Aneurysm Formation via VSMC Phenotypic Modulation and Down-regulation of ERK1/2 Activity. Li FF; Shang XK; Du XL; Chen S Curr Med Sci; 2018 Feb; 38(1):93-100. PubMed ID: 30074157 [TBL] [Abstract][Full Text] [Related]
13. Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression. Tedesco MM; Terashima M; Blankenberg FG; Levashova Z; Spin JM; Backer MV; Backer JM; Sho M; Sho E; McConnell MV; Dalman RL Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1452-7. PubMed ID: 19574559 [TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways. Zhang XJ; He C; Tian K; Li P; Su H; Wan JB Vascul Pharmacol; 2015 Oct; 73():86-95. PubMed ID: 25912763 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm. Li Y; Lu G; Sun D; Zuo H; Wang DW; Yan J PLoS One; 2017; 12(4):e0174821. PubMed ID: 28369137 [TBL] [Abstract][Full Text] [Related]
16. Receptor-interacting protein kinase 3 contributes to abdominal aortic aneurysms via smooth muscle cell necrosis and inflammation. Wang Q; Liu Z; Ren J; Morgan S; Assa C; Liu B Circ Res; 2015 Feb; 116(4):600-11. PubMed ID: 25563840 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of cyclooxygenase-2 inhibition in limiting abdominal aortic aneurysm progression in mice correlates with a differentiated smooth muscle cell phenotype. Mukherjee K; Gitlin JM; Loftin CD J Cardiovasc Pharmacol; 2012 Dec; 60(6):520-9. PubMed ID: 22967986 [TBL] [Abstract][Full Text] [Related]
18. Enhanced embryonic nonmuscle myosin heavy chain isoform and matrix metalloproteinase expression in aortic abdominal aneurysm with rapid progression. Kamijima T; Isobe M; Suzuki J; Fukui D; Arai M; Urayama H; Nishimaki K; Sekiguchi M; Kawasaki S Cardiovasc Pathol; 1999; 8(5):291-5. PubMed ID: 10533961 [TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet. Metghalchi S; Vandestienne M; Haddad Y; Esposito B; Dairou J; Tedgui A; Mallat Z; Potteaux S; Taleb S PLoS One; 2018; 13(3):e0193737. PubMed ID: 29494675 [TBL] [Abstract][Full Text] [Related]
20. Increased galectin-3 levels are associated with abdominal aortic aneurysm progression and inhibition of galectin-3 decreases elastase-induced AAA development. Fernandez-García CE; Tarin C; Roldan-Montero R; Martinez-Lopez D; Torres-Fonseca M; Lindhot JS; Vega de Ceniga M; Egido J; Lopez-Andres N; Blanco-Colio LM; Martín-Ventura JL Clin Sci (Lond); 2017 Nov; 131(22):2707-2719. PubMed ID: 28982723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]